Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. However, it is advised to contact the doctor immediately if you miss a scheduled dose of this medicine.
Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Verteporfin (moderate)
This medicine is used for the treatment of a wet type of age-related macular degeneration, an eye disease that impairs central vision making difficult to read, drive, or perform other daily activities.
This medicine is used for the treatment of diabetic retinopathy (a condition of damage to the retina due to diabetes) in patients with or without diabetic macular edema.
This medicine is used for the treatment of macular edema, a condition that occurs due to the accumulation of fluids in the macula, an area in the center of the retina which may result in vision loss.
This medicine is used for the treatment of diabetic macular edema (DME), a condition that occurs due to the accumulation of fluids in the macula, an area in the center of the retina in patients with diabetes.
Blindness
Blurred vision
Dizziness
Eye pain
Irregular heartbeat
Unexplained weight loss (rare)
Back pain (rare)
This medicine is not recommended for use if you have a known allergy to Patizra Injection 10 mg/mL 1 Vial or any other inactive ingredient present along with it.
This medicine is not recommended for use in patients with infectious eye diseases due to the increased risk of worsening of the patient's condition.